Medicare Enrolled
Dr. Firas El Sabbagh, MD
Cardiovascular Disease · Fleming Island, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. El Sabbagh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El Sabbagh? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. El Sabbagh
Dr. Firas El Sabbagh is a cardiovascular disease in Fleming Island, FL, with 18 years in practice. Based on federal Medicare data, Dr. El Sabbagh performed 7,757 Medicare services across 4,532 unique beneficiaries.
Between the years covered by Open Payments, Dr. El Sabbagh received a total of $33,386 from 43 pharmaceutical and/or device companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. El Sabbagh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 11% volume in FL$ $33,386 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,757
Medicare services
Top 11% in FL for cardiovascular disease
4,532
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~431 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 2,218 | $6 | $11 |
| Office visit, established patient (30-39 min) | 1,172 | $96 | $249 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 871 | $20 | $53 |
| Electrocardiogram (EKG), 12-lead | 530 | $11 | $29 |
| Programming of dual lead pacemaker system | 308 | $60 | $151 |
| Office visit, established patient (20-29 min) | 260 | $54 | $163 |
| Evaluation of cardiac rhythm monitor system | 192 | $38 | $93 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 163 | $20 | $53 |
| Hospital follow-up visit, moderate complexity | 154 | $64 | $158 |
| Heart rhythm recording of continous external ekg over 8-15 days | 152 | $9 | $25 |
| Initial hospital admission, high complexity | 117 | $135 | $382 |
| Hospital follow-up visit, high complexity | 103 | $93 | $227 |
| Remote pacemaker/defibrillator monitoring, 90 days | 95 | $15 | $45 |
| Programming of multiple lead implantable defibrillator system | 86 | $80 | $203 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 67 | $21 | $51 |
| Repair of left upper heart chamber with implant with review by radiologist | 66 | $649 | $1,655 |
| Ultrasonic guidance for blood vessel access | 66 | $12 | $47 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 60 | $26 | $80 |
| Office visit, established patient, complex (40-54 min) | 54 | $141 | $353 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 52 | $9 | $25 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 52 | $254 | $711 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 51 | $19 | $47 |
| Initial hospital admission, moderate complexity | 48 | $105 | $264 |
| Evaluation of implantable heart and blood vessel monitoring system | 47 | $42 | $100 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 47 | $257 | $712 |
| Ultrasound of heart with probe in esophagus, with report | 45 | $81 | $247 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 45 | $2 | $16 |
| Programming of heart rhythm stimulation after drug infusion | 43 | $67 | $198 |
| Programming of dual lead implantable defibrillator system | 40 | $68 | $179 |
| Transitional care management services for problem of high complexity | 38 | $213 | $534 |
| Remote pacemaker monitoring, 90 days | 36 | $22 | $60 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 35 | $780 | $2,069 |
| Programming of multiple lead pacemaker system | 34 | $64 | $161 |
| New patient office visit (45-59 min) | 32 | $114 | $333 |
| Measurement of heart blood flow and respiration | 30 | $20 | $51 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 30 | $15 | $30 |
| Programming of single lead pacemaker system | 29 | $53 | $130 |
| Programming of single lead implantable defibrillator system | 29 | $62 | $156 |
| Insertion of heart rhythm monitor under skin | 28 | $3,227 | $8,343 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 26 | $6 | $22 |
| Transitional care management services for problem of at least moderate complexity | 23 | $162 | $384 |
| Hospital discharge management, 30+ min | 21 | $93 | $223 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $13 | $55 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 17 | $16 | $54 |
| Insertion of permanent leadless pacemaker using imaging guidance | 16 | $364 | $1,026 |
| External shock to heart to regulate heart beat | 16 | $87 | $220 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $10 | $26 |
| Removal of heart rhythm monitor from under the skin | 15 | $72 | $265 |
| Hospital discharge day management, 30 minutes or less | 14 | $65 | $157 |
| Insertion of implantable defibrillator system | 13 | $755 | $1,909 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $702 | $1,762 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 12 | $26 | $140 |
| Echocardiogram, transthoracic | 11 | $54 | $133 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.8% high complexity
0.6% medium
86.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,386
Total received (2018-2024)
Avg $4,769/year across 7 years
Top 10% in FL for cardiovascular disease
43
Companies
387
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,891 (71.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,912 (17.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,582 (10.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$20,482
2023$2,710
2022$2,353
2021$851
2020$382
2019$2,730
2018$3,878
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$12,093
Boston Scientific Corporation
$7,844
Biosense Webster, Inc.
$5,141
Medtronic Vascular, Inc.
$2,479
Medical Device Business Services, Inc.
$2,023
Abbott Laboratories
$898
PFIZER INC.
$424
Novartis Pharmaceuticals Corporation
$317
Impulse Dynamics (USA) Inc.
$220
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$175
CVRx, Inc.
$163
Merck Sharp & Dohme LLC
$160
iRhythm Technologies, Inc.
$130
E.R. Squibb & Sons, L.L.C.
$124
Actelion Pharmaceuticals US, Inc.
$103
CardioFocus, Inc.
$103
SANOFI-AVENTIS U.S. LLC
$88
AtriCure, Inc.
$71
Amgen Inc.
$70
AstraZeneca Pharmaceuticals LP
$60
Innovation Technologies Inc
$59
United Therapeutics Corporation
$50
ABIOMED
$48
BIOTRONIK INC.
$47
Janssen Pharmaceuticals, Inc
$44
Lundbeck LLC
$42
Alnylam Pharmaceuticals Inc.
$41
Philips Electronics North America Corporation
$40
Amarin Pharma Inc.
$34
MEDICOMP INC
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Merck Sharp & Dohme Corporation
$27
Bardy Diagnostics, Inc.
$25
Novo Nordisk Inc
$24
Covidien LP
$22
Philips North America LLC
$22
Acutus Medical, Inc.
$22
Regeneron Healthcare Solutions, Inc.
$18
Aziyo Biologics, Inc.
$16
Kiniksa Pharmaceuticals, Ltd.
$16
Braemar Manufacturing, LLC
$15
Astellas Pharma US Inc
$14
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 75.1% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5091) Amb Mon & Diag Und · (CK4) MCOT · ABRE · ABSORBATACK · ADAPTA · AFFERA MAPPING SYSTEM · AMPLATZER AMULET · AVEIR · Accent Pacemaker · Adapta · Arcalyst · Arctic Front · Assurity Pacemaker · Attain · Azure · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARTO 3 · CHANTIX · CLARIA MRI QUAD CRT-D SURESCAN · COBALT DR MRI SURESCAN · COMPIA MRI QUAD CRT-D SURESCAN · Cardiac Monitor · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · CartoSound · Confirm Rx · Corlanor · ECM · ELIQUIS · EMBLEM · ENSITE PRECISION · ENTRESTO · EVERA MRI XT DR SURESCAN · Edarbyclor · Epi-Sense Guided Coagulation System with VisiTrax · FARXIGA · GENERAL THERAPIES · GENERAL - THERAPIES · HEARTLIGHT SYSTEM · IRRISEPT · Impella · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MULTAQ · Merlin Connectivity and Remote · Micra · MitraClip System · Models · NA · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PULSESELECT · Paso · QDOT MICRO Catheter · Quadra Assura CRT Defibrillator · REVEAL LINQ · Repatha · Reveal LINQ · Rhythmia Mapping System · THERMOCOOL SMARTTOUCH · TYVASO · UPTRAVI · V-Loc · VERQUVO · VYNDAQEL · Vascepa · Visitag · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (72%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for cardiovascular disease in FL.
Equivalent to $430 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
149
Per 100K population
66.7
County median income
$86,094
Nearest hospital
HCA FLORIDA ORANGE PARK HOSPITAL
5.3 mi
5.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. El Sabbagh is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), and high industry engagement (low-engagement, top 10%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. El Sabbagh experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. El Sabbagh performed 2,218 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El Sabbagh receive payments from pharmaceutical companies?
Yes. Dr. El Sabbagh received a total of $33,386 from 43 companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El Sabbagh's costs compare to other cardiovascular diseases in Fleming Island?
Dr. El Sabbagh's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El Sabbagh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Fleming Island
Browse cardiovascular diseases in Fleming Island ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology